We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1201
Manchester United
MANU
$3.52B
| $0 | ﹤0.01% |
1
| – | – |
2023 Q1
3 quarters
|
|
1202
DELISTED
Monroe Capital Corp
MRCC
| – | – |
-2,000
| Closed | -$15K | – |
|
1203
Nuveen California Municipal Value Fund
NCA
$277M
| – | – |
-1,884
| Closed | -$16K | – |
|
1204
NIO
NIO
$8.49B
| $0 | ﹤0.01% |
50
| – | – |
2022 Q1
7 quarters
|
|
1205
Nokia
NOK
$50.8B
| $0 | ﹤0.01% |
6
| – | – |
2023 Q2
2 quarters
|
|
1206
NETSCOUT
NTCT
$2.81B
| – | – |
-1,996
| Closed | -$56K | – |
|
1207
Nuveen ESG Emerging Markets Equity ETF
NUEM
$458M
| – | – |
-1,296
| Closed | -$34K | – |
|
1208
Occidental Petroleum Corp Warrants
OXY.WS
$38.5B
| $0 | ﹤0.01% |
6
| – | – |
2022 Q1
7 quarters
|
|
1209
Invesco NASDAQ 100 ETF
QQQM
$107B
| $0 | ﹤0.01% |
+1
| New | +$156 |
2023 Q4
0 quarters
|
|
1210
Quantum Computing Inc
QUBT
$1.45B
| $0 | ﹤0.01% |
225
| – | – |
2022 Q1
7 quarters
|
|
1211
Rentokil
RTO
$10.7B
| – | – |
-569
| Closed | -$21K | – |
|
1212
Sana Biotechnology
SANA
$689M
| $0 | ﹤0.01% |
100
| – | – |
2022 Q1
7 quarters
|
|
1213
SandRidge Energy
SD
$532M
| $0 | ﹤0.01% |
2
| – | – |
2022 Q1
7 quarters
|
|
1214
iShares Short-Term National Muni Bond ETF
SUB
$12.7B
| – | – |
-600
| Closed | -$62K | – |
|
1215
DELISTED
2seventy bio
TSVT
| $0 | ﹤0.01% |
33
| – | – |
2022 Q1
7 quarters
|
|
1216
Under Armour Class C
UA
$1.99B
| $0 | ﹤0.01% |
56
| – | – |
2022 Q1
7 quarters
|
|
1217
United Bankshares
UBSI
$6.31B
| – | – |
-1,600
| Closed | -$45K | – |
|
1218
Unum
UNM
$14.5B
| – | – |
-392
| Closed | -$19K | – |
|
1219
Valaris Ltd Warrants
VAL.WS
$802M
| $0 | ﹤0.01% |
4
| – | – |
2023 Q2
2 quarters
|
|
1220
Vanguard Short-Term Treasury ETF
VGSH
$35.1B
| – | – |
-5
| Closed | – | – |
|
1221
Vuzix
VUZI
$186M
| $0 | ﹤0.01% |
+55
| New | +$150 |
2023 Q4
0 quarters
|
|
1222
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.12B
| – | – |
-15
| Closed | -$1K | – |
|
1223
DELISTED
Vaxart
VXRT
| $0 | ﹤0.01% |
200
| – | – |
2022 Q1
7 quarters
|
|
1224
Woodside Energy
WDS
$45.1B
| – | – |
-722
| Closed | -$17K | – |
|
1225
DELISTED
ZimVie
ZIMV
| $0 | ﹤0.01% |
10
| – | – |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.